NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region

... Pharma for Pylera (R) , an innovative 3-in-1 capsule therapy for the eradication of Helicobacter ... over the last ten years, is a patented 3-in-1 capsule therapy. Each Pylera (R) capsule contains bismuth subcitrate potassium, ...

New Report Just Published: World Endoscopy Systems Market Report

... Suites II-2 Confocal Microendoscopes II-3 capsule Endoscopy II-3 High Definition Endoscopy ... (includes corresponding Graph/Chart) II-8 capsule Endoscopy II-9 Table 4: Leading Players in the Global capsule Endoscopes Market (2008E): Percentage ...

BMP Sunstone Acquires 'Runchang Capsule' and Related LFHC Technology

... acquire "Runchang capsule," a liquid- filled hard capsule (LFHC) used to treat constipation. Sunstone will ... The Company plans to start promoting the Runchang capsule in the Chinese market in late 2009. Zhiqiang ... Officer of BMP Sunstone, commented, "The Runchang capsule is a natural plant-based medicine for ...

NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules

... capsules in 2007, giving it a 50% share of the capsule market. Its experience, expertise and ... and encapsulation due to its leading edge capsule manufacturing technology and formulation ... innovation. As the leading global gelatin capsule manufacturer, Capsugel is the most ...

FMC Corporation and Pronova BioPharma Announce Agreement To Develop New Alginate-Based Capsule Products

... agreement to develop products using a novel capsule technology developed by FMC. The alginate-based capsule technology is expected to significantly ... trials in early 2009 and launch of the new capsule is expected in 2010-2011. FMC's novel ...

AOBO Announces New Product Launch

... Boke Nasal Spray Brand - - Diversifies Product Offering with capsule Formulation - American Oriental Bioengineering, Inc. (NYSE: AOB ... network, and the strength of the Boke brand, we believe that the Jingwei capsule could become one of AOBO's leading products over time. We are confident ...

Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients

... PhD., remarked, "These results demonstrate that Oramed's oral insulin capsule had a good safety profile and was effective on patients with type 1 ... through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's ...

Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009

... formulation of this antihypertensive is the world's first in capsule form, making it easier to swallow. Sales of more than 500,000 capsules are ... including lower cost of active pharmaceutical ingredients (API), the capsule formulation, greater efficacy and reduced side effects. Sales of ...

NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance

... oral capsules, which is widely recognized as the world leader in capsule manufacturing. Staffan Stromberg, Vice President of Technical ... have signed these contracts with global leaders in high capacity API and capsule production. We project these agreements should cover the high sales ...

Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules

... ANDA with the FDA containing a Paragraph IV certification for the 8 mg eq. capsule strength of Razadyne ER on March 1, 2006. Barr amended its ANDA on March 10, 2006 to include the 16 mg eq. and 24 mg eq. capsule strengths in its filing. Following receipt of the notice from the FDA that ...

FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting

... courses of moderately emetogenic chemotherapy. A single 0.5 mg ALOXI capsule is administered approximately one hour prior to the start of ... and repeat courses of moderately emetogenic chemotherapy. One ALOXI 0.5 mg capsule is administered approximately one hour prior to the start ...

China Kangtai Cactus Biotech Announces Record Second Quarter Results

... products such as Cactus Protein Nutrient, Cactus Calcium Peptide Soft capsule and Cactus Shuxin capsule by Chinese customers and expanded distribution. Gross profit for the ...

Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit

... U.S. patent infringement litigation pertaining to Impax's proposed generic capsule formulation of Wyeth's EFFEXOR XR(R) antidepressant have been approved by ... Wyeth has granted Impax a license that would permit Impax to launch its capsule formulation of Effexor XR on or after June 1, 2011, subject to earlier ...

Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan

... risk that regulatory authorities may find our resubmission of the indiplon capsule NDA incomplete or insufficient or otherwise unapprovable or that approval ... a marketing partner on reasonable terms or at all; risk that the indiplon capsule labeling granted by regulatory authorities may limit the commercial ...

Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist

... via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at ...

Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis

... quarter of 2009. DR Cysteamine is Raptor's proprietary enteric-coated micro-bead formulation of cysteamine bitartrate contained in a gelatin capsule and designed for increased absorption, less frequent dosing and improved tolerability relative to the current standard of care. Published studies ...

Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009

... The Mercury Project targets counties within 31 provinces in the PRC to promote our 'Gan Wang' Compound, our Paracetamol and Amantadine Hydrochloride capsule -- an over-the-counter drug for the treatment of influenza. As with hepatitis, influenza affects a large portion of the population in the People's ...

ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week

... June 1, 2009, 3:30-3:45 PM About CCX282-B (Traficet-EN) Traficet-EN is an orally-available small molecule drug which is administered in capsule form and which is believed to control the inappropriate immune system response underlying inflammatory bowel disease (IBD) by blocking the CCR9 ...

Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD

... AEROLIZER should not be used to treat acute symptoms. Acute symptoms should be treated with fast-acting rescue inhalers. Do not use more than one capsule twice daily. FORADIL AEROLIZER should be used with caution in patients with cardiovascular disorders. FORADIL AEROLIZER is not a substitute for ...

Sinobiopharma Announces SFDA Approval of Anti-Hypertension Drug Perindopril

... with significant competitive advantages, including lower cost active pharmaceutical ingredients (API), and being the first in the world to offer capsule formulation, which is not only easier to swallow, but also has greater efficacy and reduced side effects compared to earlier versions of the drug. ...

American Oriental Bioengineering Reports First Quarter 2009 Financial Results

... of 2009, roughly flat to the prior year period, reflecting continued demand for Boke nasal spray and Jinji Yimucao products and a shift of Jinji capsule products from OTC to prescription sales. Nutraceutical products generated revenue of approximately $8.9 million in the first quarter of 2009, up ...

Sirion Therapeutics Supplemental New Drug Application for Durezol(TM) to Treat Uveitis is Accepted for Review by the FDA

... in 5-15% of subjects in clinical studies with Durezol included corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, and blepharitis. Other ocular adverse reactions occurring in 1-5% ...

The Elmasonic S Ultrasonic Cleaner: Designed for the Scientific Laboratory

... labs, in particular, can employ large Elmasonic S baths to clean stainless steel, Delrin®, and Teflon® plastic parts from tablet and capsule manufacturing equipment between batches. In addition to cleaning validation, The Elmasonic S units are used by drug companies for solvent degassing ...

Oramed Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference (November 11, 2008; NYC)

... & Renshaw Conference will give Oramed an important platform to present the accomplishments we have achieved in our development of an oral insulin capsule and our unique position as a technology pioneer in the field of oral delivery solutions," said Kidron. For more information about Rodman & Renshaw ...

One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study

... in dactylitis, though the changes were not statistically significant with the 50 mg dose. Enthesitis, an inflammation of a tendon, ligament or joint capsule insertion to the bone, and dactylitis, a swelling of digits in the hands or feet, are estimated to affect more than one-third of people with ...

Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies

... morning at the Modern Mucosal Vaccines, Adjuvants & Microbicides (MMVAM) international conference in Porto, Portugal. Delivery of flu vaccine via a capsule rather than an injection offers critical advantages, particularly in the case of a pandemic. The Vaxart vaccine formulation can withstand ambient ...

Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™

... said. In a double-blind, placebo-controlled, FDA-approved human trial, 40 Type 2 diabetics consumed three time a day (before each meal) a capsule containing either 250 mg of Emulin™ or a placebo. Participants were divided into four sub-groups: placebo only; placebo and metformin, a ...

Beaumont Doctor's Invention Improves Cataract Surgery Outcomes

... eyeball behind the lens, can move into the front of the eye when the lens is not fully supported. This movement can lead to complications such as capsule tears, zonular dialysis, and dislocation of the lens into the back of the eye, requiring the patient to have an additional surgery by a retina ...

Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more

... will paint the inside walls of this chamber, heating the metal walls and causing them to emit X-rays that will fill the can, bombard a small plastic capsule in the can's center, implode the capsule, and trigger the fusion of tritium and deuterium inside. Lead researcher Christopher A. Haynam with LLNL ...

New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone)

... drug candidates to King Pharmaceuticals in November 2005. About ORADUR ORADUR is a proprietary technology designed to transform short-acting oral capsule dosage forms into sustained release oral products, with the added benefit of being less prone to abuse than other controlled release dosage forms on ...

China Medicine Announces Solid First Quarter 2008 Results

... for a number of products before year end. The Company is also on track to complete the documentation for laboratory trial results for Yutian capsule for the treatment of chronic obstructive pulmonary disease, and plans to submit them for approval by the State Food and Drug Administration in June ...

Israel's Prestigious President's Conference to Feature Oramed Pharmaceuticals' Revolutionary Oral Insulin Capsule

... focused on the development of oral delivery solutions based on proprietary technology. Oramed is currently developing an orally ingestible insulin capsule for the treatment of diabetes. The oral administration of insulin is more physiological than the current delivery method, mimicking the natural ...

Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC

... monoclonal antibodies will not lead to the development of bacterial resistance. The target of the antibody is a carbohydrate on the bacterial capsule known as PNAG. PNAG has been found to be a critical factor in the virulence and immune response to MRSA as well as non-MRSA staphylococcal infections ...

Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic

... -- Today, Ganeden Biotech announced that Sustenex(TM), its all-natural daily probiotic supplement is now available nationwide. Each Sustenex(TM) capsule contains at least 2 billion live probiotic cells of GanedenBC30, a proprietary, patented strain of Bacillus coagulans designed to help promote immune ...

Arpida Announces Full Year 2007 Financial Results

... of a Phase I study with oral iclaprim. The primary aim of the study was to assess the safety and tolerability of single ascending doses of an oral capsule formulation of iclaprim in healthy volunteers. Early in 2008, Arpida announced that it had received authorisation from the U.S. FDA to conduct a ...

BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update

... trial in patients with cutaneous t-cell lymphoma In October, BioCryst began enrolling patients in a pivotal, multinational trial of an oral capsule formulation of its lead oncology drug candidate, forodesine HCl for cutaneous t-cell lymphoma (CTCL). As presented at the 2007 American ...

China Shenghuo to Market 12Ways(R) Skin Care Products in the U.S. through Agreement with Home Shopping Group

... sales expansion if the campaign is successful. The products will be sold as a skin care kit including moisturizer, toner, skin care mask, lotion and capsule taken to improve internal health. "We are very pleased to partner with HSG to sell 12Ways, marking our entry into the U.S. market," said Mr. Gui ...

Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim

... patients with complicated Skin and Skin Structure Infections (cSSSI). The key objective of the study is to assess the clinical efficacy of an oral capsule formulation of iclaprim as step-down therapy in comparison with intravenous (IV) vancomycin in the treatment of cSSSI. The primary endpoint will be ...

Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation

... tissue. This can help reduce the risk of disease recurrence and facilitate follow-up monitoring. In remnant ablation, patients take a drink or a capsule that contains radioactive iodine, which is taken up by any remaining thyroid cells. To enhance the uptake of radioiodine, the level of thyroid ...

Neurocrine Announces Work Force Restructuring

... include, but are not limited to; risk that the Company will not be able to address issues and or requests set forth in the December 12, 2007 indiplon capsule action letter from the FDA in a timely manner if at all; risk that the Company will not be able to address issues and or requests set forth in the ...